AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer review unconfirmed
Cannabidiol (CBD) and Its Neuroprotective Effects in Animal Models of Multiple Sclerosis and Other Neurodegenerative Diseases
CBD demonstrates anti-inflammatory, antioxidant, mitochondria-protective, and neuroprotective properties in preclinical models related to multiple sclerosis and other neurodegenerative diseases. Clinical evidence, however, primarily addresses symptoms like agitation and sleep disturbances without proving disease modification.
What this does not proveThe clinical evidence remains preliminary and does not show proven disease modification. Key barriers include inconsistent bioavailability and insufficient understanding of exposure-response relationships.